Pharmaceutical News

RSS

FDA approves antibacterial drug to treat travelers' diarrhea

The U.S. Food and Drug Administration today approved Aemcolo (rifamycin), an antibacterial drug indicated for the treatment of adult patients with travelers' diarrhea caused by noninvasive strains of Escherichia coli (E. coli), not complicated by fever or blood in the stool.

17 Nov 2018

New first-line treatment for peripheral T-cell lymphoma approved by FDA

The U.S. Food and Drug Administration today expanded the approved use of Adcetris (brentuximab vedotin) injection in combination with chemotherapy for adult patients with certain types of peripheral T-cell lymphoma.

16 Nov 2018

EMA recommends first all-oral treatment to tackle deadly sleeping sickness

The European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive scientific opinion of fexinidazole, the first all-oral treatment that has been shown to be efficacious for both stages of sleeping sickness.

16 Nov 2018

Drug used to treat dizziness may slow down growth of triple-negative breast cancer

Screening Food and Drug Administration approved compounds for their ability to stop cancer growth in the lab led to the finding that the drug flunarizine can slow down the growth of triple-negative breast cancer in an animal model of the disease.

16 Nov 2018

Nexus announces availability of Arsenic Trioxide Injection in the US

Nexus Pharmaceuticals announced today the immediate availability in the United States for Arsenic Trioxide Injection. Nexus Pharmaceuticals' Arsenic Trioxide Injection is available as 10 mg per 10 mL vial for injection.

16 Nov 2018

New pharmacological agent shows promise for prevention of heart rhythm disorders

A new pharmacological agent demonstrates promising results for the prevention of a wide range of heart rhythm disorders, including both cardiac and brain injury-induced arrhythmias.

15 Nov 2018

RetiPharma secures funding to develop new peptide drug for treating degenerative eye disorders

RetiPharma has secured funding from the Novo Nordisk Foundation’s BioInnovation Institute to develop a new drug for degenerative eye disorders.

From Novo Nordisk 15 Nov 2018

Mylan and Biocon launch new insulin glargine biosimilar in the UK

Mylan N.V. and Biocon Ltd. today announced the UK launch of Semglee (Insulin Glargine solution for injection in pre-filled pen) 100 units/mL, an approved biosimilar of reference insulin glargine.

From Viatris Inc. 15 Nov 2018

Scientists try to develop portable systems that can quickly produce biologics on demand

Many life-saving medicines, including insulin, antibodies and vaccines, are derived from living cells. These "biologics" can be difficult to obtain and store on the battlefield or in remote areas.

15 Nov 2018

FDA warns against use of unapproved pain medications with implanted pumps

The U.S. Food and Drug Administration today alerted health care providers and patients about the serious complications that can occur when using medications not approved for use with implanted pumps that deliver medication into the spinal fluid to treat or manage pain.

15 Nov 2018

Researchers discover molecular basis for therapeutic actions of an African folk medicine

Researchers in the Department of Physiology & Biophysics at the University of California, Irvine School of Medicine have discovered the molecular basis for therapeutic actions of an African folk medicine used to treat a variety of illnesses and disorders including diabetes, pain, headaches, paralysis and epilepsy.

15 Nov 2018

New diabetes drugs linked to increased risk of lower-limb amputation and ketoacidosis

The use of a new class of drugs in the treatment of type 2 diabetes, so called SGLT2 inhibitors, are linked to a twofold increased risk for lower-limb amputation as well as diabetic ketoacidosis, a serious diabetes complication.

14 Nov 2018

Enable Injections enters into development agreements with UCB and Apellis Pharmaceuticals

Enable Injections, Inc., a patient-centric drug delivery combination product company developing advanced wearable devices for subcutaneous delivery of high-volume therapeutics, today announced it has entered into development agreements with Apellis Pharmaceuticals, and most recently, UCB.

14 Nov 2018

£500,000 grant could pave way for new antibiotic to battle against drug-resistant superbugs

A new antibiotic hailed as the "last line of defense" in the battle against drug-resistant superbugs such as MSRA and VRE is taking the next step in development thanks to a UK Government grant of almost £500,000.

14 Nov 2018

Breakthrough in the treatment of Restless Legs Syndrome

New research published in The Journal of Physiology presents a breakthrough in the treatment of Restless Legs Syndrome.

13 Nov 2018

Empowering the NHS through Industry Partnerships

An interview with Cara Afzal and Lee-Ann Farrell discussing the importance of industry partnerships with the NHS, and how Janssen are working to improve dementia care for Manchester and hematology services for Wales.

13 Nov 2018

Angiotensin receptor blockers improve sodium excretion in blacks

Drugs that inhibit a hormone that constricts blood vessels also help improve sodium excretion in blacks who hold onto too much sodium in the face of stress, investigators report.

13 Nov 2018

Suicidal patients with prescribed access to psychotropic drugs should be closely monitored

As prescriptions for psychotropic drugs increase, researchers at the University of Colorado Anschutz Medical Campus have found that prescribed access to anti-anxiety and anti-psychotic medications may make it easier for some patients to use the drugs in attempted suicides.

13 Nov 2018

Diabetes medication reduces risk of heart failure hospitalization

In the largest trial to date to assess cardiovascular outcomes for an important class of diabetes medications, researchers have found that dapagliflozin markedly reduced the risk of hospitalization for heart failure in a broad population of patients with diabetes.

12 Nov 2018

Fish oil and vitamin D pills no guard against cancer or serious heart trouble

A widely anticipated study has concluded that neither vitamin D nor fish oil supplements prevent cancer or serious heart-related problems in healthy older people, according to research presented Saturday at the American Heart Association Scientific Sessions. Researchers defined serious heart problems as the combined rate of heart attacks, stroke and heart-related deaths.

12 Nov 2018

Pharmaceutical News

FDA approves antibacterial drug to treat travelers' diarrhea

New first-line treatment for peripheral T-cell lymphoma approved by FDA

EMA recommends first all-oral treatment to tackle deadly sleeping sickness

Drug used to treat dizziness may slow down growth of triple-negative breast cancer

Nexus announces availability of Arsenic Trioxide Injection in the US

New pharmacological agent shows promise for prevention of heart rhythm disorders

RetiPharma secures funding to develop new peptide drug for treating degenerative eye disorders

Mylan and Biocon launch new insulin glargine biosimilar in the UK

Scientists try to develop portable systems that can quickly produce biologics on demand

FDA warns against use of unapproved pain medications with implanted pumps

Researchers discover molecular basis for therapeutic actions of an African folk medicine

New diabetes drugs linked to increased risk of lower-limb amputation and ketoacidosis

Enable Injections enters into development agreements with UCB and Apellis Pharmaceuticals

£500,000 grant could pave way for new antibiotic to battle against drug-resistant superbugs

Breakthrough in the treatment of Restless Legs Syndrome

Empowering the NHS through Industry Partnerships

Angiotensin receptor blockers improve sodium excretion in blacks

Suicidal patients with prescribed access to psychotropic drugs should be closely monitored

Diabetes medication reduces risk of heart failure hospitalization

Fish oil and vitamin D pills no guard against cancer or serious heart trouble

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News